Photo of Rand Paul
R United States Senate · Kentucky

Sen. Rand Paul

Compare
Total votes
1,037
all sessions
Attendance
96%
40 missed
Lower than 80% of chamber peers
With party
75%
of cast votes
Among the lowest in the chamber
Bipartisan score
13%
some cross-party votes
Higher than 98% of chamber peers
Sponsored
488
bills & resolutions
Lower than 94% of chamber peers
Committees
13
assignments
488 bills and resolutions

Sponsored bills

Total
488
Primary
173
Co-sponsor
315
This page
488
matching current filters
Co-sponsor S 1512
In committee · Florida Senate · Co-sponsor
DIRECT Act of 2023

Maddy summaryThis bill amends federal meat and poultry inspection laws to allow businesses to sell State-inspected meat and poultry products online. It permits retail stores, restaurants, and similar establishments to ship these products directly to household consumers via mail or carrier, in normal retail quantities, within the U.S. (excluding exports). The change specifically applies to products inspected under state programs, not federal inspection, and affects small businesses that previously could not legally sell such products online. The law does not change inspection standards but removes a barrier to direct-to-consumer e-commerce for these products.

In committee May 10, 2023 1 co-sponsor
Co-sponsor SRES 200
Passed · Florida Senate · Co-sponsor
A resolution expressing support for the designation of the week of April 30, 2023, through May 6, 2023, as "National Small Business Week" to celebrate the contributions of small businesses and entrepreneurs in every community in the United States.

Maddy summaryThis Senate resolution (SRES 200) expresses support for designating April 30-May 6, 2023, as "National Small Business Week" to honor small businesses and entrepreneurs across the United States. It recognizes that small businesses (over 33 million nationwide supporting 62 million jobs) are vital to the U.S. economy and highlights their resilience. The resolution specifically calls for celebrating their contributions, acknowledging challenges they face, and supporting efforts to improve access for underserved small businesses. As a symbolic gesture - not a law - it does not create new policies or funding but formally recognizes small business impact.

Passed May 4, 2023 1 co-sponsor
Co-sponsor S 1363
In committee · Florida Senate · Co-sponsor
Repeal CFPB Act

Maddy summaryS 1363 would repeal the Consumer Financial Protection Act of 2010, eliminating the Consumer Financial Protection Bureau (CFPB) as a federal agency. This bill directly affects consumer financial oversight by removing the agency responsible for enforcing rules on banks, lenders, and other financial institutions. The key mechanism is the restoration of pre-2010 financial regulations that were amended or replaced by the CFPB's creation, reverting to the regulatory framework that existed before the bureau was established.

In committee Apr 27, 2023 1 co-sponsor
Co-sponsor S 1359
In committee · Florida Senate · Co-sponsor
CLAIM Act

Maddy summaryThe CLAIM Act protects insurance companies from federal penalties when providing coverage to cannabis businesses operating legally under state laws. It prohibits federal agencies from banning, penalizing, or forcing insurers to cancel policies solely because a business is cannabis-related, or because an owner, operator, or employee works in the cannabis industry. The bill also shields insurers from federal liability for offering such coverage or investing income from it, as long as the business complies with state or tribal cannabis regulations. It does not require insurers to cover cannabis businesses but ensures they can do so without federal interference. This primarily affects insurers and cannabis businesses operating within legal state frameworks, addressing a key barrier to accessing insurance.

In committee Apr 27, 2023 1 co-sponsor
Co-sponsor S 1247
In committee · Florida Senate · Co-sponsor
Terry Technical Correction Act

Maddy summaryS 1247, the Terry Technical Correction Act, clarifies that retroactivity provisions under the First Step Act of 2018 apply to crack-cocaine offenders sentenced before the Fair Sentencing Act of 2010, including low-level offenses under specific sections of the Controlled Substances Act (like 21 U.S.C. 841(b)(1)(C)). It amends the First Step Act to explicitly define "covered offense" to include 14 specific crack-related violations and their attempts/conspiracies. This technical correction ensures eligible offenders previously denied retroactive sentencing adjustments due to a Supreme Court interpretation can now seek review. The bill directly affects individuals convicted of certain crack offenses before 2010 who were excluded from retroactivity under prior court rulings. It makes no new policy changes but corrects an interpretation gap in existing law.

In committee Apr 20, 2023 1 co-sponsor
Co-sponsor S 1201
In committee · Florida Senate · Co-sponsor
Employee Rights Act

Maddy summaryThis bill amends key labor laws to strengthen worker protections and clarify union election processes. It requires employers to provide voter lists for union elections with only one employee-chosen contact detail (like email or phone), mandates secret ballot elections for union representation, and restricts union dues from funding non-representational activities without written employee consent for at least 35 days. The bill also clarifies joint employment standards, making it harder for companies to avoid responsibility for workers' pay and conditions, and adds tribal sovereignty protections to labor law definitions. These changes directly affect employers, unions, and employees in collective bargaining contexts.

In committee Apr 19, 2023 1 co-sponsor
Co-sponsor S 1128
In committee · Florida Senate · Co-sponsor
Ensuring Access to Generic Medications Act

Maddy summaryThis bill creates a legal process allowing generic drug manufacturers to challenge inaccurate patent listings by brand-name drug companies. Specifically, it permits generic applicants to file lawsuits seeking court orders to correct or delete misleading "use codes" in patent records related to a drug's method of use. This directly affects generic drug makers and brand-name sponsors who list patents for drug applications under FDA approval pathways. The key mechanism requires courts to address listings that don't match actual patents, cover unrelated uses, or are overly broad, aiming to clear patent-related barriers for generic competition.

In committee Mar 30, 2023 1 co-sponsor
Co-sponsor S 1132
In committee · Florida Senate · Co-sponsor
ADAPT 2.0 Act

Maddy summaryThe ADAPT 2.0 Act (S 1132) allows U.S. drug manufacturers to seek approval for new drugs using clinical and safety data from countries where the drug is already approved, such as the United Kingdom and South Africa. It requires the FDA to review these applications within 90 days and automatically approve them if the drug meets specific criteria, including being approved in the foreign country, safe, effective, and meeting manufacturing and patent requirements. The bill mandates the FDA to establish a new Foreign Drug Review Advisory Committee to evaluate applications within 60 days and publish approval decisions online. It also requires sponsors to conduct post-approval studies for certain drugs and submit promotional materials for review before dissemination. This law directly affects drug manufacturers seeking faster U.S. market access and the FDA’s review process for foreign-approved therapies.

In committee Mar 30, 2023 1 co-sponsor
Co-sponsor S 316
Passed · Florida Senate · Co-sponsor
A bill to repeal the authorizations for use of military force against Iraq.

Maddy summaryThis bill repeals two specific legal authorizations for U.S. military force against Iraq: the 1991 authorization (Public Law 102-1) and the 2002 authorization (Public Law 107-243). If enacted, it would end the legal basis for military operations in Iraq under these two resolutions. The repeal directly affects the executive branch’s authority to use military force against Iraq under these specific laws. It does not create new policy but removes existing legal permissions.

Passed Mar 30, 2023 1 co-sponsor
Co-sponsor SJRES 22
In committee · Florida Senate · Co-sponsor
A joint resolution providing for congressional disapproval under chapter 8 of title 5, United States Code, of the rule submitted by the Department of Education relating to "Waivers and Modifications of Federal Student Loans".

Maddy summaryThis bill (SJRES 22) seeks to block a specific rule issued by the Department of Education regarding federal student loan modifications. It targets the rule titled "Waivers and Modifications of Federal Student Loans," which included a one-time debt relief program announced in October 2022. The resolution requests Congress disapprove the rule under the Congressional Review Act, preventing the Department from implementing it. If approved, the rule would have no legal effect, directly affecting how student loan borrowers could access modifications or debt relief under that specific policy.

In committee Mar 27, 2023 1 co-sponsor
Showing 231 to 240 of 488 bills
Previous 1 23 24 25 49 Next